Skip to main content
Top
Published in: Drugs & Aging 8/2019

01-08-2019 | Antidepressant Drugs | Original Research Article

Reducing Psychotropic Drug Use in Nursing Homes in Belgium: An Implementation Study for the Roll-Out of a Practice Improvement Initiative

Authors: Maarten Wauters, Monique Elseviers, Laurine Peeters, Dirk De Meester, Thierry Christiaens, Mirko Petrovic

Published in: Drugs & Aging | Issue 8/2019

Login to get access

Abstract

Background and Objective

Psychotropic drug use is high in nursing homes in Belgium. A practice improvement initiative (including education, professional support and the transition towards person-centred care) achieved significant reductions in psychotropic drug use. The initiative outline was transcribed into a general intervention template, and consequently implemented in five nursing homes (in mixed locations and with a mixed character) in preparation for a future broader roll-out in Belgium. The impact of the intervention on the use of psychotropic drugs in these five nursing homes is reported in this paper.

Methods

The general intervention template was fitted into the individual nursing home setting. Education for the nursing home personnel on psychotropic drugs and non-pharmacological alternatives, as well as details for a transition to person-centred care was provided. Psychotropic drug use was recorded using a dynamic cohort study design with cross-sectional observations (November 2016–November 2017).

Results

At baseline, participants’ (n = 677) mean age was 85.6 years (range 54–109 years), with 72.6% female. Mean medication intake was 8.5 (range 1–22), predominantly central nervous system drugs (Anatomic Therapeutic Chemical classification N, 88.8%). Long-term (> 3 months) psychotropic drug use (62.0%) and concomitant psychotropic drug use (31.5% taking two or more medications) were high. After 12 months, the prevalence of long-term psychotropic drug use decreased significantly (from 62.0 to 52.9%, p < 0.001), likewise the combined use of psychotropic drugs (from 31.5 to 24.0%, p = 0.001). The decrease in the prevalence of antidepressant and hypnosedative use was significant (respectively, from 32.2 to 23.4%, p < 0.001, and from 35.3 to 28.7%, p = 0.006) in contrast to antipsychotic use (from 17.1 to 15.9%, p = 0.522).

Conclusions

The stand-alone adaptation of the previously reported initiative using a general template was possible. This intervention resulted in a significant decrease in psychotropic drug use (predominantly hypnosedatives and antidepressants) among nursing home residents after 12 months.
Literature
1.
go back to reference Schüssler S, Dassen T, Lohrmann C. Care dependency and nursing care problems in nursing home residents with and without dementia: a cross-sectional study. Aging Clin Exp Res. 2016;28:973–82.CrossRefPubMed Schüssler S, Dassen T, Lohrmann C. Care dependency and nursing care problems in nursing home residents with and without dementia: a cross-sectional study. Aging Clin Exp Res. 2016;28:973–82.CrossRefPubMed
2.
go back to reference Ivanova I, Wauters M, Stichele RV, Christiaens T, De Wolf J, Dilles T, et al. Medication use in a cohort of newly admitted nursing home residents (Ageing@NH) in relation to evolving physical and mental health. Arch Gerontol Geriatr. 2018;75:202–8.CrossRefPubMed Ivanova I, Wauters M, Stichele RV, Christiaens T, De Wolf J, Dilles T, et al. Medication use in a cohort of newly admitted nursing home residents (Ageing@NH) in relation to evolving physical and mental health. Arch Gerontol Geriatr. 2018;75:202–8.CrossRefPubMed
3.
go back to reference Mann E, Köpke S, Haastert B, Pitkälä K, Meyer G, Alanen H, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr. 2009;9:18.CrossRefPubMedPubMedCentral Mann E, Köpke S, Haastert B, Pitkälä K, Meyer G, Alanen H, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr. 2009;9:18.CrossRefPubMedPubMedCentral
4.
go back to reference Hollingworth SA, Siskind DJ, Nissen LM, Robinson M, Hall WD. Patterns of antipsychotic medication use in Australia 2002–2007. Aust N Z J Psychiatry. 2010;44:372–7.CrossRefPubMed Hollingworth SA, Siskind DJ, Nissen LM, Robinson M, Hall WD. Patterns of antipsychotic medication use in Australia 2002–2007. Aust N Z J Psychiatry. 2010;44:372–7.CrossRefPubMed
5.
go back to reference Sterke CS, van Beeck EF, van der Velde N, Ziere G, Petrovic M, Looman CWN, et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52:947–55.CrossRefPubMed Sterke CS, van Beeck EF, van der Velde N, Ziere G, Petrovic M, Looman CWN, et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52:947–55.CrossRefPubMed
6.
go back to reference National Institute for Health and Care Excellence (UK). Dementia: assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (UK); 2018. National Institute for Health and Care Excellence (UK). Dementia: assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (UK); 2018.
7.
go back to reference Barnes TRE, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry. 2012;201:221–6.CrossRefPubMed Barnes TRE, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry. 2012;201:221–6.CrossRefPubMed
8.
go back to reference Selbæk G, Kirkevold Ø, Engedal K. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes: a 12-month follow-up study. Am J Geriatr Psychiatry. 2008;16:528–36.CrossRefPubMed Selbæk G, Kirkevold Ø, Engedal K. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes: a 12-month follow-up study. Am J Geriatr Psychiatry. 2008;16:528–36.CrossRefPubMed
9.
go back to reference Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed
10.
go back to reference Azermai M, Elseviers M, Petrovic M, Van Bortel L, Vander Stichele R. Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol. 2011;26:12–20.CrossRefPubMed Azermai M, Elseviers M, Petrovic M, Van Bortel L, Vander Stichele R. Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol. 2011;26:12–20.CrossRefPubMed
11.
go back to reference Elseviers MM, Vander Stichele RR, Van Bortel L. Quality of prescribing in Belgian nursing homes: an electronic assessment of the medication chart. Int J Qual Health Care. 2014;26:93–9.CrossRefPubMed Elseviers MM, Vander Stichele RR, Van Bortel L. Quality of prescribing in Belgian nursing homes: an electronic assessment of the medication chart. Int J Qual Health Care. 2014;26:93–9.CrossRefPubMed
12.
go back to reference Anrys PMS, Strauven GC, Foulon V, Degryse J-M, Henrard S, Spinewine A. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018;19:884–90.CrossRefPubMed Anrys PMS, Strauven GC, Foulon V, Degryse J-M, Henrard S, Spinewine A. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018;19:884–90.CrossRefPubMed
13.
go back to reference Azermai M, Wauters M, De Meester D, Renson L, Pauwels D, Peeters L, et al. A quality improvement initiative on the use of psychotropic drugs in nursing homes in Flanders. Acta Clin Belg. 2017;72:163–71.CrossRefPubMed Azermai M, Wauters M, De Meester D, Renson L, Pauwels D, Peeters L, et al. A quality improvement initiative on the use of psychotropic drugs in nursing homes in Flanders. Acta Clin Belg. 2017;72:163–71.CrossRefPubMed
14.
15.
go back to reference Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä S-L, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55:809–17.CrossRefPubMed Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä S-L, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55:809–17.CrossRefPubMed
16.
go back to reference Stevenson DG, Decker SL, Dwyer LL, Huskamp HA, Grabowski DC, Metzger ED, et al. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry. 2010;18:1078–92.CrossRefPubMedPubMedCentral Stevenson DG, Decker SL, Dwyer LL, Huskamp HA, Grabowski DC, Metzger ED, et al. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry. 2010;18:1078–92.CrossRefPubMedPubMedCentral
17.
go back to reference Stock KJ, Amuah JE, Lapane KL, Hogan DB, Maxwell CJ. Prevalence of, and resident and facility characteristics associated with antipsychotic use in assisted living vs. long-term care facilities: a cross-sectional analysis from Alberta, Canada. Drugs Aging. 2017;34:39–53. Stock KJ, Amuah JE, Lapane KL, Hogan DB, Maxwell CJ. Prevalence of, and resident and facility characteristics associated with antipsychotic use in assisted living vs. long-term care facilities: a cross-sectional analysis from Alberta, Canada. Drugs Aging. 2017;34:39–53.
18.
go back to reference van der Spek K, Gerritsen DL, Smalbrugge M, Nelissen-Vrancken MHJMG, Wetzels RB, Smeets CHW, et al. Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate: the PROPER I-study. Int Psychogeriatrics. 2016;28:1589–95. van der Spek K, Gerritsen DL, Smalbrugge M, Nelissen-Vrancken MHJMG, Wetzels RB, Smeets CHW, et al. Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate: the PROPER I-study. Int Psychogeriatrics. 2016;28:1589–95.
19.
go back to reference Allers K, Dörks M, Schmiemann G, Hoffmann F. Antipsychotic drug use in nursing home residents with and without dementia. Int Clin Psychopharmacol. 2017;32:213–8.CrossRefPubMed Allers K, Dörks M, Schmiemann G, Hoffmann F. Antipsychotic drug use in nursing home residents with and without dementia. Int Clin Psychopharmacol. 2017;32:213–8.CrossRefPubMed
20.
go back to reference MacPherson S, Davison TE, Hallford D, Mellor D, Seedy M, Bird M, et al. Behavioral symptoms of dementia that present management difficulties in nursing homes: staff perceptions and their concordance with informant scales. J Gerontol Nurs. 2016;43:34–43.PubMed MacPherson S, Davison TE, Hallford D, Mellor D, Seedy M, Bird M, et al. Behavioral symptoms of dementia that present management difficulties in nursing homes: staff perceptions and their concordance with informant scales. J Gerontol Nurs. 2016;43:34–43.PubMed
21.
go back to reference Tjia J, Lemay CA, Bonner A, Compher C, Paice K, Field T, et al. Informed family member involvement to improve the quality of dementia care in nursing homes. J Am Geriatr Soc. 2017;65:59–65.CrossRefPubMed Tjia J, Lemay CA, Bonner A, Compher C, Paice K, Field T, et al. Informed family member involvement to improve the quality of dementia care in nursing homes. J Am Geriatr Soc. 2017;65:59–65.CrossRefPubMed
22.
go back to reference Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;(3):CD007726. Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;(3):CD007726.
23.
go back to reference Van Leeuwen E, Petrovic M, van Driel ML, De Sutter AI, Vander Stichele R, Declercq T, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018;3:CD007726. Van Leeuwen E, Petrovic M, van Driel ML, De Sutter AI, Vander Stichele R, Declercq T, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018;3:CD007726.
24.
go back to reference Van Leeuwen E, Petrovic M, van Driel ML, De Sutter AI, Stichele R Vander, Declercq T, et al. Discontinuation of long-term antipsychotic drug use for behavioral and psychological symptoms in older adults aged 65 years and older with dementia. J Am Med Dir Assoc. 2018;19:1009–14. Van Leeuwen E, Petrovic M, van Driel ML, De Sutter AI, Stichele R Vander, Declercq T, et al. Discontinuation of long-term antipsychotic drug use for behavioral and psychological symptoms in older adults aged 65 years and older with dementia. J Am Med Dir Assoc. 2018;19:1009–14.
25.
go back to reference Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ. Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry. 2014;204:98–107.CrossRefPubMed Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ. Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry. 2014;204:98–107.CrossRefPubMed
26.
go back to reference de Souto Barreto P, Lapeyre-Mestre M, Cestac P, Vellas B, Rolland Y. Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation. Br J Clin Pharmacol. 2016;81:759–67.CrossRef de Souto Barreto P, Lapeyre-Mestre M, Cestac P, Vellas B, Rolland Y. Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation. Br J Clin Pharmacol. 2016;81:759–67.CrossRef
27.
go back to reference Westbury J, Jackson S, Gee P, Peterson G. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr. 2010;22:26–36.CrossRefPubMed Westbury J, Jackson S, Gee P, Peterson G. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr. 2010;22:26–36.CrossRefPubMed
28.
go back to reference Westbury J, Tichelaar L, Peterson G, Gee P, Jackson S. A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr. 2011;23:1260–9.CrossRefPubMed Westbury J, Tichelaar L, Peterson G, Gee P, Jackson S. A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr. 2011;23:1260–9.CrossRefPubMed
29.
go back to reference Westbury JL, Gee P, Ling T, Brown DT, Franks KH, Bindoff I, et al. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust. 2018;208:398–403.CrossRefPubMed Westbury JL, Gee P, Ling T, Brown DT, Franks KH, Bindoff I, et al. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust. 2018;208:398–403.CrossRefPubMed
30.
go back to reference Richter T, Mann E, Meyer G, Haastert B, Köpke S. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med. Dir Assoc. 2012;13(187):e7–13. Richter T, Mann E, Meyer G, Haastert B, Köpke S. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med. Dir Assoc. 2012;13(187):e7–13.
31.
go back to reference Hughes CM, Lapane K, Watson MC, Davies HTO. Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs Aging. 2007;24:81–93.CrossRefPubMed Hughes CM, Lapane K, Watson MC, Davies HTO. Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs Aging. 2007;24:81–93.CrossRefPubMed
32.
go back to reference Leten L, Azermai M, Wauters M, De Lepeleire J. Een kwalitatieve exploratie van het chronisch gebruik van psychofarmaca in woonzorgcentraA qualitative exploration of the chronic use of psychotropic drugs in nursing homes. Tijdschr Gerontol Geriatr. 2017;48:177–86.CrossRefPubMed Leten L, Azermai M, Wauters M, De Lepeleire J. Een kwalitatieve exploratie van het chronisch gebruik van psychofarmaca in woonzorgcentraA qualitative exploration of the chronic use of psychotropic drugs in nursing homes. Tijdschr Gerontol Geriatr. 2017;48:177–86.CrossRefPubMed
33.
go back to reference Cabrera E, Sutcliffe C, Verbeek H, Saks K, Soto-Martin M, Meyer G, et al. Non-pharmacological interventions as a best practice strategy in people with dementia living in nursing homes: a systematic review. Eur Geriatr Med. 2015;6:134–50.CrossRef Cabrera E, Sutcliffe C, Verbeek H, Saks K, Soto-Martin M, Meyer G, et al. Non-pharmacological interventions as a best practice strategy in people with dementia living in nursing homes: a systematic review. Eur Geriatr Med. 2015;6:134–50.CrossRef
34.
go back to reference Chen R-C, Liu C-L, Lin M-H, Peng L-N, Chen L-Y, Liu L-K, et al. Non-pharmacological treatment reducing not only behavioral symptoms, but also psychotic symptoms of older adults with dementia: a prospective cohort study in Taiwan. Geriatr Gerontol Int. 2014;14:440–6.CrossRefPubMed Chen R-C, Liu C-L, Lin M-H, Peng L-N, Chen L-Y, Liu L-K, et al. Non-pharmacological treatment reducing not only behavioral symptoms, but also psychotic symptoms of older adults with dementia: a prospective cohort study in Taiwan. Geriatr Gerontol Int. 2014;14:440–6.CrossRefPubMed
35.
go back to reference Martin P, Tannenbaum C, Ahmed S, Tamblyn R, Benedetti A. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education. JAMA Intern Med. 2014;174:890–8.CrossRefPubMed Martin P, Tannenbaum C, Ahmed S, Tamblyn R, Benedetti A. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education. JAMA Intern Med. 2014;174:890–8.CrossRefPubMed
36.
go back to reference Lawrence V, Fossey J, Ballard C, Moniz-Cook E, Murray J. Improving quality of life for people with dementia in care homes: making psychosocial interventions work. Br J Psychiatry. 2012;201:344–51.CrossRefPubMed Lawrence V, Fossey J, Ballard C, Moniz-Cook E, Murray J. Improving quality of life for people with dementia in care homes: making psychosocial interventions work. Br J Psychiatry. 2012;201:344–51.CrossRefPubMed
Metadata
Title
Reducing Psychotropic Drug Use in Nursing Homes in Belgium: An Implementation Study for the Roll-Out of a Practice Improvement Initiative
Authors
Maarten Wauters
Monique Elseviers
Laurine Peeters
Dirk De Meester
Thierry Christiaens
Mirko Petrovic
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 8/2019
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-019-00686-5

Other articles of this Issue 8/2019

Drugs & Aging 8/2019 Go to the issue